OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F8219 for the supply of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505013142716 and PR 7017630308. The total contract value is $174.40, with the award dated July 24, 2026, and the delivery order falls under the parent contract SPE2DX25D9900. The item is intended for federal use, with the Department of Defense as the overseeing agency, though no specific delivery location or point of contact details are provided. The solicitation was issued through the DIBBS system, and the award reflects a direct procurement without any set-aside designation.
General Info
Agency
Contract Value
$174.4NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
